Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Pathophysiology of Cardiac Performance

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Creatine Supplementation in Endurance and Mixed-Sport Contexts: A Scoping Review of Performance, Recovery, and Body Composition.

Nutrients·2026

Same author

How Genes Meet Diet in LCHAD Deficiency: Nutrigenomics of Fatty Acid Oxidation Disorder.

International journal of molecular sciences·2025

Same author

A Preliminary Study of Nutrients Related to the Risk of Relative Energy Deficiency in Sport (RED-S) in Top-Performing Female Amateur Triathletes: Results from a Nutritional Assessment.

Nutrients·2025

Same author

Plant-based diets contribute to lower circulating leptin in healthy subjects independently of BMI.

Acta biochimica Polonica·2022

Same author

Dietary Lipids and Dyslipidemia in Chronic Kidney Disease.

Nutrients·2021

Same author

Expanded Role of a Dietitian in Monitoring a Gluten-Free Diet in Patients with Celiac Disease: Implications for Clinical Practice.

Nutrients·2021

Search research articles

Related Experiment Video

Updated: May 21, 2026

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Published on: October 25, 2019

[Leptin as a mediator between obesity and cardiac dysfunction].

Joanna Karbowska¹, Zdzisław Kochan

¹Katedra Biochemii, Gdański Uniwersytet Medyczny, Gdańsk.

Postepy Higieny I Medycyny Doswiadczalnej (Online)

|June 19, 2012

Summary

Obesity increases heart disease risk due to elevated leptin, a hormone linked to cardiac dysfunction. Lowering leptin through weight loss may prevent heart problems in obese individuals.

Area of Science:

Cardiology
Endocrinology
Metabolic Syndrome

Background:

Obesity is a major risk factor for heart disease.
Leptin, a hormone from adipose tissue, is elevated in obesity and linked to energy homeostasis.
Growing evidence suggests leptin's role in cardiac dysfunction.

Purpose of the Study:

To investigate the association between leptin levels and cardiac structure and function.
To explore leptin's direct effects on cardiomyocytes and cardiac remodeling.
To assess the potential of reducing leptin for preventing cardiac dysfunction in obesity.

Main Methods:

Analysis of a large prospective study correlating leptin levels with coronary heart disease.
Examination of associations between plasma leptin and heart rate in hypertensive and heart transplant patients.

More Related Videos

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

Related Experiment Videos

Last Updated: May 21, 2026

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Published on: October 25, 2019

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

In vitro studies on human and rodent cardiomyocytes to assess leptin's direct effects.

Review of existing literature on leptin's role in heart failure and cardiac hypertrophy.

Main Results:

Leptin is an independent risk factor for coronary heart disease.
Elevated leptin levels correlate with increased heart rate, blood pressure, myocardial wall thickness, and left ventricular mass.
Leptin directly induces cardiomyocyte hypertrophy, hyperplasia, and cardiac extracellular matrix remodeling.
Leptin influences energy substrate utilization in cardiac tissue.

Conclusions:

Leptin may adversely affect cardiac structure and function, potentially via direct action or sympathetic nervous system activation.
Chronic hyperleptinemia significantly increases the risk of cardiac disorders.
Caloric restriction and weight loss, leading to reduced leptin levels, may prevent cardiac dysfunction in obese patients.